Phoenix Onglyza Lawsuit

According to the Food and Drug Administration (FDA), people using Onglyza have a very high risk of contracting congestive heart failure. A recent FDA advisory meeting mandated that the labels used on Onglyza should have clear warnings about the risk of heart failure, a warning that was not included in the labels previously. This lack of warnings has led to a rise in people injured by this drug filing Phoenix Onglyza lawsuits.

Have you or your loved one taken Onglyza and suffered from heart failure? Has your loved one died from heart failure after taking Onglyza? Well, you may be eligible for compensation from the manufacturer, AstraZeneca. Of course, you should know that it is a large company with a team of experienced mass tort attorneys in-house for handling such lawsuits.

However, you don’t have to worry because we are here to help. Contact Dalimonte Rueb Stoller now. Our Phoenix mass tort lawyers will give you a free consultation, review your claim, and advise you on your legal rights.

Table of Contents

What Is The Link Between Onglyza And Heart Failure?

In America, cardiovascular diseases are some of the leading causes of death for both men and women. Each year, the CDC (center for disease control) reports at least 610,000 fatalities because of heart disease. That means that at least 4 in every 4 deaths in the US is because of heart disease in the US.

People diagnosed with type 2 diabetes and prescribed with Onglyza have reported an alarming rate of health issues related to the use of this medication. The FDA started investigating Onglyza and how it increases the risk of heart diseases especially after numerous concerns in the US. The final report revealed a lot of worrying issues as such manufacturers of Onglyza and Kombiglyze XR have to add warnings of heart failure on the drug labels.

Is There A Link Between Onglyza And Pancreatic Cancer?

Onglyza stimulates the pancreas to release more insulin. As such, it has been linked to people having issues with pancreatic cancer or pancreatitis. In 2013, a study focused on how DPP-4 inhibitors impacted the pancreas. The study revealed that people with type 2 diabetes who have been using Onglyza have an increased chance of getting an enlarged pancreas. They also have a high risk of getting precancerous cellular changes in the pancreas thereby resulting in pancreatic cancer.

In March 2013, the FDA issued a drug safety alert revealing that the body was researching the suggestions that people using incretin mimetic to treat type 2 diabetes have a high risk of precancerous cellular changes and pancreatitis. The drugs categorized as incretin mimetics were Januvia, Nesina, Byetta, and Onglyza.

In 2014, another study was conducted by researchers who analyzed data collected from a clinical trial for people using Onglyza. The study identified no signs of increased risk of pancreatitis or pancreatic cancer.

Is There A Relationship Between Onglyza And Thyroid Cancer?

Victoza, similar to Onglyza, is an incretin mimetic identified to cause acute pancreatitis and malignant thyroid cancer in rodents who were given the drug in clinical dosages. The FDA issued a safety warning in June 2011, informing people of the risk of thyroid cancer from using Victoza. Note that, FDA has also received a lot of warnings of people who have later received a diagnosis of thyroid cancer after continued use of prescription incretin mimetics such as Januvia (sitagliptin) and Byetta (exenatide).

Has Onglyza Been Recalled?

There has been no recall of Onglyza yet and it’s a low probability that it will be done soon. Besides these, the issues of cancer, heart failure, or other fatal health issues can’t be ignored after using the drug. Vioxx was recalled since it caused heart attacks, strokes, and other cardiovascular issues. The same is expected of Onglyza and any other incretin mimetics known to increase heart failure. Currently, the only action that has been taken for these medications is to mandate manufacturers to mention these side effects into the labels.

A lawyer reviewing a claim for a client in Phoenix filing an Onglyza lawsuit.

Are There Any Current Lawsuits Against Onglyza?

Drug injury lawsuits are not usually classified as a class action. Note that, with a class action, a few plaintiffs will represent the others with similar cases against the drug manufacturers/company. You are required to file the case individually. In January 2018, a judicial panel ordered that all the existing lawsuits against Onglyza and Kombiglyze should be consolidated in Kentucky. By May of the same year, 100 of these cases were consolidated into the litigation labeled MDL 2809. However, other lawsuits are still pending in California.

Can You File A Phoenix Onglyza Lawsuit If It Has Not Been Recalled?

As mentioned, the FDA has recommended that all the labels of Onglyza should have clear warnings about the risk of heart failure. However, many people are still asking why the warnings were not included when the product was released 10 years ago. If this is what is happening currently, then a lot of patients who took Onglyza in the last 10 years were not aware of the increased heart risks. As such, they might have suffered some serious side effects without an idea of the cause.

According to the law in Phoenix, AZ, patients who were prescribed Onglyza and suffered heart failure, are eligible for compensation. That’s because the drug manufacturers failed to provide people with enough safety warnings about the potential outcome.

Get Legal Help From An Onglyza Attorney At Dalimonte Rueb Stoller

Have you or your loved one suffered heart issues or heart failure because of Onglyza? Has your loved one been hospitalized or died because of Onglyza? Well, you need to consult the class action attorneys in our firm, Dalimonte Rueb Stoller. We are here to help and have worked with different people all over the country.

We have the best knowledge on how the big pharmaceutical companies such as AstraZeneca and Bristol Myers Squibb are mandated by law to ensure that patients and doctors are aware of the risks associated with their drugs. By failing to do this, these pharmaceutical companies are liable for any damages by people who have used their drugs.

Over the years, we have handled similar drug cases to Onglyza at Dalimonte Rueb Stoller. As such, we understand all the flaws associated with such a case. If you want to face the drug manufacturers behind Onglyza, we should be your first choice of attorneys. We can make sure that you win the case and get the right compensation for your damages. Call our Phoenix class action law firm at (833) 44-DRLAW and get a free consultation. We will do a complete review of your case and give you more information about your rights as a plaintiff.

Testimonials
Featured FAQs
Free Case Review
Dalimonte Rueb Stoller Logo
Let's Get Started With a Free Case Review